News
The first hemophilia B patient in Germany received gene therapy Hemgenix, covered by public healthcare with efficacy-tied reimbursement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback